These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 11006708)

  • 1. [Senile macular degeneration. Photodynamic therapy stabilizes vision].
    MMW Fortschr Med; 2000 Aug; 142(35):46-7. PubMed ID: 11006708
    [No Abstract]   [Full Text] [Related]  

  • 2. Two-year visual outcomes after photodynamic therapy in age-related macular degeneration patients with or without polypoidal choroidal vasculopathy lesions.
    Tsuchiya D; Yamamoto T; Kawasaki R; Yamashita H
    Retina; 2009; 29(7):960-5. PubMed ID: 19491727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the potential acuity meter in predicting visual acuity after photodynamic therapy for choroidal neovascularization.
    Smith BT; Vander JE; Regillo CD; Ho AC
    Ophthalmic Surg Lasers Imaging; 2006; 37(1):6-11. PubMed ID: 16468545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low power vs standard power transpupillary thermotherapy in patients with age-related macular degeneration and subfoveal choroidal neovascularization ineligible for photodynamic therapy.
    Hogan AC; Kilmartin DJ
    Eye (Lond); 2006 Jun; 20(6):649-54. PubMed ID: 16082398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does lesion size determine the success rate of photodynamic therapy for age-related macular degeneration?
    Sivaprasad S; Saleh GM; Jackson H
    Eye (Lond); 2006 Jan; 20(1):43-5. PubMed ID: 15832188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Visual acuity and magnification requirement after ranibizumab in patients with wet age-related macular degeneration].
    Kloos P; Bernasconi P; Estermann S; Bachmann B; Rutishauser Y; Thölen A
    Klin Monbl Augenheilkd; 2008 May; 225(5):385-91. PubMed ID: 18454378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Why can't I see at night and in low light as well as I used to?
    Johns Hopkins Med Lett Health After 50; 2011 May; 23(3):8. PubMed ID: 21528517
    [No Abstract]   [Full Text] [Related]  

  • 8. Macular degeneration: the major cause of severe vision loss in persons fifty-five years or older.
    Haik GM; Terrell WL; Haik GM
    J Miss State Med Assoc; 1989 Jul; 30(7):207-10. PubMed ID: 2789290
    [No Abstract]   [Full Text] [Related]  

  • 9. The BITA telescope: a first impression.
    Harkins T; Maino JH
    J Am Optom Assoc; 1991 Jan; 62(1):28-31. PubMed ID: 1813489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vision rehabilitation for patients with age-related macular degeneration.
    Rubin GS
    Eye (Lond); 2001 Jun; 15(Pt 3):430-5. PubMed ID: 11450769
    [No Abstract]   [Full Text] [Related]  

  • 11. [Ginkgo extract in impaired vision--treatment with special extract EGb 761 of impaired vision due to dry senile macular degeneration].
    Fies P; Dienel A
    Wien Med Wochenschr; 2002; 152(15-16):423-6. PubMed ID: 12244891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Photodynamic therapy for age-related macular degeneration].
    Gomi F
    Nippon Ganka Gakkai Zasshi; 2006 Sep; 110(9):681-2. PubMed ID: 17025222
    [No Abstract]   [Full Text] [Related]  

  • 13. NICE recommends photodynamic therapy for certain patients with macular degeneration.
    Mayor S
    BMJ; 2003 Sep; 327(7417):698. PubMed ID: 14512456
    [No Abstract]   [Full Text] [Related]  

  • 14. Vision rehabilitation with biofeedback training.
    Nido MD; Markowitz SN
    Can J Ophthalmol; 2018 Jun; 53(3):e83-e84. PubMed ID: 29784180
    [No Abstract]   [Full Text] [Related]  

  • 15. Age related macular degeneration. New hope for a common problem comes from photodynamic therapy.
    Bressler NM
    BMJ; 2000 Dec; 321(7274):1425-7. PubMed ID: 11110721
    [No Abstract]   [Full Text] [Related]  

  • 16. Innovative strategies for adaptation to loss of vision.
    Riazi A; Dain SJ; Boon MY; Bridge C
    Clin Exp Optom; 2011 Jan; 94(1):98-102. PubMed ID: 21198837
    [No Abstract]   [Full Text] [Related]  

  • 17. [Our experience with the comprehensive treatment of arterisoclerotic macular dystrophies].
    Sandul LA
    Oftalmol Zh; 1978; 33(5):370-1. PubMed ID: 704028
    [No Abstract]   [Full Text] [Related]  

  • 18. Visual impairment in the elderly.
    Taylor S; Lightman S
    Br J Hosp Med (Lond); 2005 Dec; 66(12):662-3. PubMed ID: 16417103
    [No Abstract]   [Full Text] [Related]  

  • 19. Senile macular degeneration in northern India.
    Jain IS; Prasad P; Gupta A; Ram J; Dhir SP
    Indian J Ophthalmol; 1984; 32(5):343-6. PubMed ID: 6545319
    [No Abstract]   [Full Text] [Related]  

  • 20. [Viewpoints on the drug therapy of degenerative "senile" macular involvement].
    Sautter H; Utermann D
    Ber Zusammenkunft Dtsch Ophthalmol Ges; 1975; (73):573-85. PubMed ID: 1242983
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.